SPOTLIGHT: More debate over nursing home antipsychotic use

As we've discussed here previously, there's a hot debate going on over the use of antipsychotic medications in nursing homes to calm down agitated dementia patients. That's spurred, in part, because Medicaid is paying for many of these scripts, spending $5.4 billion on atypical antipsychotics in 2005 alone. As this article notes, critics say that it would be far better to use these funds to hire more staff members to manage demented patients. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.